320 related articles for article (PubMed ID: 28481042)
1. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
[TBL] [Abstract][Full Text] [Related]
2. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
Bourgonje AR; Alexdottir MS; Otten AT; Loveikyte R; Bay-Jensen AC; Pehrsson M; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Karsdal MA; Faber KN; Mortensen JH; Dijkstra G
Aliment Pharmacol Ther; 2022 Aug; 56(4):675-693. PubMed ID: 35661188
[TBL] [Abstract][Full Text] [Related]
3. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
4. Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.
Goffin L; Fagagnini S; Vicari A; Mamie C; Melhem H; Weder B; Lutz C; Lang S; Scharl M; Rogler G; Chvatchko Y; Hausmann M
Inflamm Bowel Dis; 2016 Sep; 22(9):2041-57. PubMed ID: 27542125
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn's Disease and Ulcerative Colitis.
Domislovic V; Høg Mortensen J; Lindholm M; Kaarsdal MA; Brinar M; Barisic A; Manon-Jensen T; Krznaric Z
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233775
[TBL] [Abstract][Full Text] [Related]
6. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study.
Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J
PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931
[TBL] [Abstract][Full Text] [Related]
7. Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study.
van Haaften WT; Mortensen JH; Dige AK; Grønbæk H; Hvas CL; Bay-Jensen AC; Karsdal MA; Olinga P; Manon-Jensen T; Dijkstra G
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00217. PubMed ID: 33094957
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
[TBL] [Abstract][Full Text] [Related]
9. Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Front Med (Lausanne); 2022; 9():933872. PubMed ID: 35903311
[TBL] [Abstract][Full Text] [Related]
10. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
11. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
[TBL] [Abstract][Full Text] [Related]
12. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.
Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J
Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218
[TBL] [Abstract][Full Text] [Related]
13. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy.
Nielsen SH; Mygind ND; Michelsen MM; Bechsgaard DF; Suhrs HE; Genovese F; Nielsen HB; Brix S; Karsdal M; Prescott E; Kastrup J
Eur J Prev Cardiol; 2018 May; 25(7):719-727. PubMed ID: 29436257
[TBL] [Abstract][Full Text] [Related]
14. Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897710
[TBL] [Abstract][Full Text] [Related]
15. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.
Manon-Jensen T; Sun S; Lindholm M; Domislović V; Giuffrida P; Brinar M; Mazza G; Pinzani M; Krznarić Z; Di Sabatino A; Karsdal MA; Mortensen JH
United European Gastroenterol J; 2021 Mar; 9(2):268-278. PubMed ID: 33351719
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
Dovrolis N; Drygiannakis I; Filidou E; Kandilogiannakis L; Arvanitidis K; Tentes I; Kolios G; Valatas V
Inflamm Bowel Dis; 2019 Jan; 25(2):217-225. PubMed ID: 30346536
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
18. Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis.
Nielsen MJ; Thorburn D; Leeming DJ; Hov JR; Nygård S; Moum B; Saffioti F; Gilja OH; Boberg KM; Mazza G; Røsjø H; Pinzani M; Karlsen TH; Karsdal MA; Vesterhus M
Aliment Pharmacol Ther; 2018 Jul; 48(2):179-189. PubMed ID: 29851098
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
Jenkins RG; Simpson JK; Saini G; Bentley JH; Russell AM; Braybrooke R; Molyneaux PL; McKeever TM; Wells AU; Flynn A; Hubbard RB; Leeming DJ; Marshall RP; Karsdal MA; Lukey PT; Maher TM
Lancet Respir Med; 2015 Jun; 3(6):462-72. PubMed ID: 25770676
[TBL] [Abstract][Full Text] [Related]
20. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy.
Holm Nielsen S; Sun S; Bay-Jensen AC; Karsdal M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Thamsborg G; Madsen OR; Møller J; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Dec; 24(1):279. PubMed ID: 36564778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
